Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy for the Treatment of Metastatic Prostate Cancer

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement